Pfizer, Merck launch large new trials of oral COVID-19 drugs

Pfizer, Merck launch large new trials of oral COVID-19 drugs

Source: 
BioPharma Dive
snippet: 

Pfizer and Merck & Co. each launched pivotal clinical studies of new experimental oral COVID-19 drugs, building on previous work to provide outpatient alternatives for patients.